We are beyond excited to share our latest work on the role of PRDX6 in #ferroptosis out today in @MolecularCell and spearheaded by two exceptional postdocs in our lab, Junya and @eikan_em !
https://t.co/DJnxngaIUl
I am honored to have received a Poster Award at Redox Week in Sendai. Many thanks to everyone who took the time to engage in such enjoyable discussions and share memorable moments!
Redox Week in Sendaiでポスター賞をいただきました。ご交流いただきました皆様ありがとうございました🙇♀️
Thrilled that our design made the cover of the current @MolecularCell issue! Congratulations again to the team @eikan_em and Junya as well as the companion paper by @AngeliFriedmann group!
Thrilled that our design made the cover of the current @MolecularCell issue! Congratulations again to the team @eikan_em and Junya as well as the companion paper by @AngeliFriedmann group!
It’s an honor to see that we made it to this list again! #ferroptosis research is thriving! Also, congratulations to all colleagues and collaborators, including @SJD956, @AngeliFriedmann, @Linkermann_Lab, @bstockwell, and many others!
Highly Cited Researchers 2024
🎉 Congratulations to our outstanding scientists
Prof. Fabian Theis, Director of the Institute for
Computational Biology and Head of the Computational Health Center, @CompHealthMuc,
Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death, @Conrad_Lab,
Prof. Matthias Blüher, Director of the Helmholtz Institute for Metabolic, Obesity & Vascular Research and Head of the Research Group Clinical Obesity Research @HIMAG_Leipzig,
Prof. Klaus F. X. Mayer, Research Group Head, Plant Genome and Systems Biology,
and Prof. Triantafyllos Chavakis for being recognized as Highly Cited Researchers 2024 by @Clarivate !
This prestigious distinction highlights their significant and far-reaching impact across their respective fields, based on data from the Web of Open Science Core Collection and expert qualitative analysis by the INSTITUTE FOR SCIENTIFIC INFORMATION, INC. (ISI).
We are incredibly proud of their dedication to advancing science and driving innovation. 👏
#HighlyCited2024 #HelmholtzMunich #ScientificExcellence
@fabian_theis@ClarivateAG@helmholtz_ai@helmholtz_en
Fascinating story on #ferroptosis in a complex medical syndrome! Worth reading! Congrats to the authors for getting this paper out in @Cell_Metabolism 🙌🏻
New paper from our lab 🤩📣NEW CKM gene and pathway!!! Human genetics identify convergent signals in mitochondrial LACTB-mediated lipid metabolism in cardiovascular-kidney-metabolic syndrome: @Cell_Metabolism https://t.co/8gtRrJB9b1
Very pleased to be listed as a highly cited researcher — a testament to a great network of trainees and collaborators and the ever-growing #ferroptosis community!
https://t.co/JgFCUCRnWk
🎉 Congratulations to Prof. Matthias Tschöp on being awarded the esteemed Lichtenberg medal 2025 by the Göttingen Academy of Sciences and Humanities, in recognition of his groundbreaking discoveries in the field of #medicine.
👉 https://t.co/kmFiHJ3nlB
🏅The award, which represents the highest honor of the Academy, recognizes particularly outstanding and publicly respected scientists from all over the world.
Matthias Tschöp, CEO at #HelmholtzMunich and Alexander von Humboldt Professor at @TU_Muenchen, is a pioneer in metabolic disease research. His work significantly advances the understanding of #obesity, #diabetes and related disorders.
@adw_goe
#LichtenbergMedal #MetabolicScience #Innovation #Tirzepatide #Obesity #Diabetes #PrecisionTherapy #prevention
It’s an honor to see that we made it to this list again! #ferroptosis research is thriving! Also, congratulations to all colleagues and collaborators, including @SJD956, @AngeliFriedmann, @Linkermann_Lab, @bstockwell, and many others!
IT’S HERE! The Highly Cited Researchers 2024 list has now been published. #HighlyCited2024
Discover the world’s influential #researchers: https://t.co/X5by5IZf5L
@Conrad_Lab of @HelmholtzMunich is leading our growing understanding of the role of #ferroptosis in human disease, especially #cancer and #neurodegenerative diseases. Recent studies on selenium carrier protein, PRDX-6, from the lab highlight new therapeutic opportunities.